Line 34: | Line 34: | ||
<div class="segmentDiv"> | <div class="segmentDiv"> | ||
<div class="centerContainer"> | <div class="centerContainer"> | ||
+ | <img style="float:left; margin-left:20px; margin-right:20px; margin-top:10px;" height=250 width=400 src="https://static.igem.org/mediawiki/2017/f/f4/T--Lethbridge--partcollection.png" id="imageHalf"> | ||
+ | |||
<p class="text12j">The N<i>ex</i>t <i>vivo</i> system is made up of >40 unique parts encoding both protein and RNA components. The main focus of our team this year was to submit all 38 TX-TL protein components to the registry as a <a href="https://2017.igem.org/wiki/index.php?title=Team:Lethbridge/Part_Collection" id="pageLink">collection of parts</a> that anyone could use to produce their own N<i>ex</i>t <i>vivo</i> system. Several of these TX-TL components were already in the registry but were under different expression control, lacked purification tags, and/or were not codon optimized for expression in <i>E. coli</i>. As such we sought to <a href="https://2017.igem.org/Team:Lethbridge/Improve" id="pageLink">improve these parts</a> for future use.</p> | <p class="text12j">The N<i>ex</i>t <i>vivo</i> system is made up of >40 unique parts encoding both protein and RNA components. The main focus of our team this year was to submit all 38 TX-TL protein components to the registry as a <a href="https://2017.igem.org/wiki/index.php?title=Team:Lethbridge/Part_Collection" id="pageLink">collection of parts</a> that anyone could use to produce their own N<i>ex</i>t <i>vivo</i> system. Several of these TX-TL components were already in the registry but were under different expression control, lacked purification tags, and/or were not codon optimized for expression in <i>E. coli</i>. As such we sought to <a href="https://2017.igem.org/Team:Lethbridge/Improve" id="pageLink">improve these parts</a> for future use.</p> | ||
Revision as of 21:05, 30 October 2017
Overview
Parts Collection
The Next vivo system is made up of >40 unique parts encoding both protein and RNA components. The main focus of our team this year was to submit all 38 TX-TL protein components to the registry as a collection of parts that anyone could use to produce their own Next vivo system. Several of these TX-TL components were already in the registry but were under different expression control, lacked purification tags, and/or were not codon optimized for expression in E. coli. As such we sought to improve these parts for future use.